Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.

Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.

About

Company description

Founded in 2013, Nanjing Heron Pharmaceutical Science & Technology Company Limited is an innovation-oriented company engaged in the research, development and industrial production of new drugs and first-time generic drugs in China. Active Vitamin D derivatives synthesis and Regulatory Service with Technical Support are the two critical characteristics of Heron Pharma. In 2016, Heron Pharma successfully landed on the NEEQ Stock market (National Equities Exchange and Quotations, Stock Code: 870070). We established a GMP-certified production site for the scale-up and industrial production of APIs, SODFs, soft gel capsule, small volume injections and topical dosage forms. In 2018, an Accreditation Certificate of Foreign Drug Manufacturer was certified to Heron’s manufacturing base by Japan Pharmaceutical and Medical Devices Agency (PMDA, No. AG10500666).

Heron (Shanghai) Pharmaceutical Science and Technology Co., Ltd. is a holding company of Nanjing Heron Pharma responsible for the export business of full range vitamin D analogs, including Alfacalcidol, Calcifediol Monohydrate, Calcipotriol Monohydrate, Calcitriol Anhydrous, Doxercalciferol, Eldecalcitol, Maxacalcitol, Paricalcitol and Tacalcitol Monohydrate. Their formulations can also be supplied upon request, including tablets, soft gel capsules, injections, ointment and cream. The intermediates and impurities reference substance are also available at USP, EP, BP or JP grade.  We also take the distribution of below APIs: Bisacodyl, Dexlansoprazole Sodium, Nonoxynol, Tranilast, Vanillin and their formulations. 

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Capsules |Creams, Lotions, Ointments |Custom Manufacturing of Dosage Form Drugs More

News about Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.

Heron Pharma attended CPhI China 2019

7 Oct 2019

Heron Pharma attended CPhI China 2019

Many thanks to the customers visiting us on  at booth E2G39 on CPhI China 2019. Let's meet again on CPhI China 2020 at W2B25 in Shanghai, Jun. 22-24th 2020.

Read more

7 Oct 2019

Accreditation Certification of Foreign Drug Manufacturer from Japan PMDA

In 2018, an Accreditation Certificate of Foreign Drug Manufacturer was certified to Heron’s manufacturing base by Japan Pharmaceutical and Medical Devices Agency (PMDA, No. AG10500666).

Read more
Heron (Shangai) Pharmaceutical Science and Technology Co., Ltd.

Contact information

Address

Telephone

Website

View all contact information